Herald Investment Management’s Mesa Laboratories MLAB Stock Holding History

Herald Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-42,500	Closed	-$4.23M	–	50
2026 Q2	$4.23M	Sell	42,500 -7,500	-15%	-$755K	0.57%	59
2026 Q1	$4.39M	Hold	50,000	–	–	0.61%	49
2025 Q4	$3.92M	Hold	50,000	–	–	0.51%	58
2025 Q3	$3.34M	Buy	50,000 +37,500	+300%	+$2.7M	0.45%	64
2025 Q2	$1.18M	Hold	12,500	–	–	0.17%	87
2025 Q1	$1.48M	Buy	12,500 +5,083	+69%	+$693K	0.28%	83
2024 Q4	$977K	Buy	+7,417	New	+$911K	0.16%	87

Other funds holding MLAB

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Herald Investment Management's MLAB Position: Q3 2026 in Review

Herald Investment Management sold out of Mesa Laboratories (MLAB) in Q3 2026, closing a stake of 42,500 shares — an estimated $4.23M sold.

Herald Investment Management first reported a position in MLAB in Q4 2024 and held it in 7 quarters. The position peaked at $4.39M in Q1 2026. 4 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

Herald Investment Management reported no remaining Mesa Laboratories position as of Q3 2026 after selling out during the quarter.
Herald Investment Management sold 42,500 Mesa Laboratories shares in Q3 2026, an estimated $4.23M.
Herald Investment Management first reported a position in Mesa Laboratories in Q4 2024 and held it in 7 quarters.
Herald Investment Management's Mesa Laboratories position peaked at $4.39M in Q1 2026.
4 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Herald Investment Management's 13F filing for Q3 2026.